Approval · Notice of Compliance 5505 · 1994
STREPTASE: Notice of Compliance 5505
Issued October 5, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5505
- Date
- October 5, 1994
- Company
- Hoechst Roussel Canada Inc.Laval, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in manufacturing
- Therapeutic class
- Fibrinolytic agent
Products in this notice
Medicinal ingredients
- STREPTOKINASE 250,000 UNIT per VIAL
- STREPTOKINASE 750,000 UNIT per VIAL
- STREPTOKINASE 1,500,000 UNIT per VIAL